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Introduction. We aimed to determine whether gait velocity is as useful as a balance test, a self-report measure of freezing of gait
(FOG), and/or a measure of motor symptom severity for predicting falls among people with Parkinson Disease (PD). Methods.
Fifty-six individuals with idiopathic PD completed a baseline assessment consisting of these measures: (1) MDS-UPDRS III, (2)
Mini-BESTest, (3) gait velocity (forward, backward, dual task, and fast), and (4) FOGQ. Retrospective fall history was collected
at baseline and six months later. Participants were considered fallers if they had two or more falls in the surveillance period.
Ability of the tests to discriminate between fallers and nonfallers was determined using ROC curves followed by pairwise statistical
noninferiority comparisons (P = .05) of the area under the ROC curve (AUC) for each test. Results. At six months, 22% (n = 21) of
the sample were fallers. Fallers diﬀered significantly from nonfallers on the MDS-UPDRS III, Mini-BESTest, backward gait velocity,
and FOGQ. The Mini-BESTest had the highest AUC and was superior to all gait velocity measures at identifying fallers. Conclusion.
A single measure of gait velocity, even in a challenging condition, may not be as eﬀective as the Mini-BESTest in identifying fallers
among people with PD.

1. Introduction
Falls are extremely dangerous and can lead to serious
complications for people with Parkinson disease (PD).
Complications associated with falls include reduced quality
of life, immobility, hip fracture, and mortality [1, 2]. Falling
is the most common reason for hospital admission for people
with PD [3]. Given the prevalence and negative impact
of falls in PD, clinicians must be equipped with measures
that are practical for use in clinical settings and accurate
in prospectively predicting falls so that interventions can be
provided to reduce fall risk.
A meta-analysis, conducted by Pickering and colleagues,
noted that the best predictor of falls in individuals with
PD is a history of two or more falls in the previous six
months [4]. While it is convenient and informative to gain
this information regarding fall history, this is not ideal for
the rehabilitation professional because the individual with

PD has already fallen. Additionally, simply asking about
fall history does not provide the clinician any information
regarding factors associated with the cause of the falls.
Factors such as postural instability, gait diﬃculty, and
other facets of mobility are significantly associated with
falls in people with PD [5, 6]. As such, it is imperative
that rehabilitation clinicians employ assessments that test
mobility-related constructs in an eﬀort to detect deficits in
mobility prior to a fall. Gaining information about future fall
risk allows for the implementation of eﬀective rehabilitation
programs to reduce fall risk and possibly prevent falls in
people with PD.
The ability to predict future falls has improved through
use of assessments that include measurements of postural
stability during static and dynamic tasks. However, these
assessments have some limitations when used in a clinical setting. Balance assessment tools often require special
training of the tester who must make subjective ratings of
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participant’s performance. Additionally, administration of
balance assessments can be time-consuming [7]. Because of
these limitations, there is a need for measures that are
objective, quick, and easy to administer. Adopting a measure
with these qualities for clinical use must be based on the
knowledge that such a measure is equally accurate as more
involved measures at predicting falls in people with PD.
Given the association between impaired gait and falls in
people with PD [6], and because it is an objective measure
that can be recorded quickly, we asked whether gait velocity is
as useful as a multi-item balance test, a self-report measure of
freezing of gait (FOG), and/or a measure of motor symptom
severity for predicting falls among people with PD. We
hypothesized that gait speed would be as accurate as the other
measures in prospectively identifying fallers.

2. Methods
2.1. Participants. Participants were recruited from the Washington University School of Medicine Movement Disorders
Center and the Volunteers for Health database. Individuals were included if they were diagnosed with “definite”
idiopathic PD [8], over the age of 40, and able to walk
without an assistive device for 15 meters. Exclusions took
place if potential participants reported any of the following:
(1) presence of any serious medical condition, (2) musculoskeletal impairment or disease that significantly impaired
their ability to walk independently, or (3) history of another
neurologic deficit or atypical parkinsonism. Baseline visits
for this study were conducted in October-December of 2009,
with six-month followups occurring in April-June of 2010.
The principal investigator (GME) recruited all participants
via phone interview and informed them that they would be
participating in a study examining how balance, walking,
and other factors influence fall risk in people with PD.
Participants were given as much time as they needed to
determine whether or not they would agree to participate. All
eligible participants provided written and informed consent
in accordance with the policies and procedures of the Human
Research Protection Oﬃce at Washington University.
2.2. Study Design. This was a prospective cohort trial. In the
Locomotor Control Laboratory at Washington University,
participants underwent a baseline assessment of gait and
balance conducted by a physical therapist (RPD) trained in
the administration of each outcome measure. At baseline,
participants were assessed oﬀ anti-PD medication, which
was considered to be greater than or equal to 12 hours
since the last anti-PD medication administration. Six months
after baseline, participants reported the number of falls since
baseline assessment.
2.3. Outcome Measures. Balance was assessed using the
Mini-Balance Evaluation Systems Test (Mini-BESTest), a
condensed version of the BESTest and contains 14 items
used to measure dynamic balance [9]. Each item is scored
on a three-point Likert scale from zero to two with two
representing no balance impairment. The Mini-BESTest has
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high interrater and intrarater reliability when used to assess
balance in people with PD [10].
Walking was evaluated using a GAITRite (CIR Systems, Havertown, PA) walkway in four gait conditions:
(1) comfortable forward (FWV), (2) backward (BWV), (3)
dual task (DTWV), and fast as possible forward (FastWV).
Participants completed three trials for each condition. These
three trials were averaged to obtain mean walking velocity
for each condition. For DTWV, participants were given a
phonemic naming task in which they were asked to name as
many words as possible that began with a certain letter. The
letter was revealed three seconds before they were instructed
to begin walking. The letters used for the three trials were
“H,” “L,” and “T.” Walking trials were conducted in the same
order for every participant: (1) FWV, (2) BWV, (3) DTWV,
and (4) FastWV.
Motor symptom severity was assessed using the Movement Disorder Society-Unified Parkinson Disease Rating
Scale III (MDS-UPDRS III) [11, 12]. The MDS-UPDRS III
consists of 33 items, each scored from zero to four, with four
representing severe symptoms. From this assessment, each
participant was assigned a Hoehn & Yahr (H&Y) stage, with
H&Y I indicating minimal PD severity and H&Y V indicating
maximal PD severity.
The Freezing of Gait Questionnaire (FOGQ) is a sixitem subjective assessment used to determine presence of
symptoms related to freezing of gait and quantify severity of
these symptoms. The FOG-Q is a reliable and valid tool that
can successfully identify more than 85% of people with PD
who experienced FOG [13].
The physical therapist conducting all assessments
recorded fall history via interview. This interview took place
only after the participants completed the assessments in
order to maintain therapist blinding to fall history. A fall
was defined as an unexpected event in which any part of
the body contacted the ground. Investigators have previously
used this definition in studies of fall prediction in people
with and without PD [14, 15]. Each participant chose from
the following responses to retrospectively report how many
times they had fallen over the six months since baseline
assessment: (1) none, (2) one time, (3) 2–10 times, (4)
weekly, or (5) daily. Participants were considered fallers
if they reported two or more falls. This criterion was
chosen because it has been previously used to characterize
individuals with PD as fallers [16], and also because any
individual might fall once by chance and as such using a
single fall to classify people may not be ideal.
2.4. Data Analysis. Independent t-tests were used to determine diﬀerences between fallers and nonfallers (P = .05).
Ability of the measures to discriminate between fallers
and nonfallers was determined using receiver operating
characteristic (ROC) curves followed by pairwise statistical
noninferiority comparisons (P = .05, one-tailed) of area
Under the Curve (AUC) for each test compared to the MiniBESTest [17, 18]. We chose to use these one-tailed tests
because the Mini-BESTest is known to be a good predictor
of falls and as such we considered it a reference measure
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Table 1: Participant demographics.

H&Y
Age
Gender

Entire sample (n = 56)
I (0), II (21), II.5 (25), III (9), IV (1),
V (0)
Mean: 2.4 (0.5)
69.5 (1.2); range 48–89
32 men/23 women (59% male)

Nonfaller (n = 44)
I (0), II (20), II.5 (18), III (6), IV (0),
V (0)
Mean: 2.3 (0.05)∗
69.6 (1.2); range 48–89
25 men/18 women (59% male)

Faller (n = 12)
I (0), II (1), II.5 (7), III (3), IV (1),
V (0)
Mean: 2.7 (0.14)∗
68.7 (3.1); range 48–82
7 men/5 women (58% male)

Values are mean (standard error) except for H&Y, which follows the format Stage (number of occurrences).
∗ P < 0.05 (nonfaller significantly diﬀerent from faller).

Table 2: Predictive values and noninferiority comparisons for all outcome measures.

Mini-BESTest
MDS-UPDRS III
FOGQ
FWV
BWV
DTWV
FastWV

AUC Cutoﬀ score Sensitivity Specificity LR+ LR− Positive posttest probability Negative posttest probability
0.80
16
0.75
0.79
3.57 0.32
50.18
8.19
0.79
58
0.50
0.88
4.17 0.57
54.02
13.81
0.78
8
0.58
0.86
4.14 0.49
53.88
12.10
0.63
1.17 m/s
0.67
0.72
2.39 0.46
40.29
11.45
0.68
0.50 m/s
0.67
0.70
2.23 0.47
38.64
11.73
0.64
0.78 m/s
0.66
0.72
2.36 0.47
39.93
11.75
0.56
1.59 m/s
0.58
0.72
2.07 0.58
36.87
14.13

to which the performance of the other measures could be
compared. All analyses were conducted using NCSS software
(NCSS, LLC, Kaysville, UT, USA).

3. Results
Baseline assessments were completed on 56 participants, of
which 12 were fallers. Sample characteristics are presented in
Table 1. Fallers and nonfallers diﬀered in H&Y stage, but not
age. All individuals who were classified as fallers at baseline
were also deemed fallers at six months and all who were
nonfallers at baseline were nonfallers at six months. As such,
prior history of two or more falls at baseline was a perfect
predictor of fall status at six months.
At baseline, fallers and nonfallers were significantly
diﬀerent on Mini-BESTest, FOGQ, BWV, and MDS-UPDRS
III, but not on FWV, DTWV, or FastWV (Figure 1).
The Mini-BESTest had the largest AUC, followed by the
MDS-UPDRS III, FOGQ, BWV, DTWV, FWV, and FastWV
(Figure 2). Noninferiority comparisons of the AUCs showed
that the Mini-BESTest was superior to gait velocity in any
gait condition but was not superior to FOGQ or MDSUPDRS III. The MDS-UPDRS III demonstrated the highest
positive posttest probability, while FastWV had the lowest
(Table 2). The highest negative posttest probability was noted
for FastWV; while the Mini-BESTest had the lowest.

4. Discussion
We aimed to determine if simple measurement of gait
velocity, during standard walking or during more challenging
gait tasks, would be as accurate as more involved measures
in predicting falls among people with PD. Contrary to our
hypothesis, gait velocity was not a good predictor of falls.
The Mini-BESTest was more accurate than gait velocity,

even when measured under challenging walking conditions.
While gait impairment has been linked to fall risk in people
with PD, our results suggest that gait velocity may not be
particularly useful for predicting falls in this group [6].
Perhaps other measures of gait, such as gait coordination
or symmetry, would be better at predicting falls in people
with mild-to-moderate PD. Asymmetry can, in fact, be
present even when gait speed is reasonably intact in people
with de novo PD [19]. However, we focused our study on
gait velocity because it is a quick, practical measure easily
obtained in clinical settings using just a stopwatch. Gait
symmetry is more diﬃcult to measure than gait velocity,
making it less practical for clinical use.
It is likely that falls are multifactorial in nature and that
suﬃcient accuracy in predicting falls cannot be obtained
through testing only a single construct. Dibble and colleagues
reported that a combination of tests, as compared to a single
test, resulted in fewer false negatives and greater changes
in posttest probability when measuring fall risk in people
with PD [20]. This may explain why the Mini-BESTest and
MDS-UPDRS III were more accurate than gait velocity in
predicting falls. Both the Mini-BESTest and MDS-UPDRS III
are batteries of tests that measure PD-specific impairments
associated with falling. While it takes more time to complete
these types of measures compared to the quick and simple
assessment of gait velocity, the limitations of multi-item
assessments may be outweighed by the superior predictive
information they provide.
In line with previous research noting that a prior
history of falls was the best predictor of future falls, our
results demonstrated that a history of falls in the past six
months was a perfect predictor of future falls [4]. This
underscores the importance of inquiring about fall history
for all professionals involved in the management of people
with PD. However, while the inquiry about fall history is
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Figure 1: Dot plots for the nonfaller and faller groups for Mini-BESTest (a), MDS-UPDRS-III (b), FOGQ (c), backward walking velocity
(d), forward walking velocity (e), fast walking velocity (f), and dual task walking velocity (g). Items in the left column are those that were
significantly diﬀerent between nonfallers and fallers.

of utmost importance, fall risk assessment should not stop
there. The results of this study as well as others demonstrate
that the utilization of standardized outcome measures can
contribute significantly to the understanding of fall risk for
people with PD [20–22]. Additionally, while the results of

this study show that these measures are not as accurate in fall
prediction as asking about fall history, the Mini-BESTest or
MDS-UPDRS III may be employed when the cognitive status
of an individual with PD is questionable and self-report of
falls may be inaccurate. Finally, information gained through
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the Greater St. Louis Chapter of the American Parkinson
Disease Association (APDA) and APDA Center for Advanced
PD Research at Washington University.

1

0.75

Sensitivity

References
0.5

0.25

0

0

0.25

Mini-BESTest
Backward vel.
Dual task vel.
Fast vel.

0.5
1-specificity

0.75

1

Forward vel.
FOG Q
MDS-UPDRS-3

Figure 2: Receiver operator characteristic (ROC) curves for the
various measures comparing accuracy in identifying fallers versus
nonfallers.

these outcome measures can be used to inform and guide
treatment for physical therapists in an eﬀort to reduce fall
risk for those with PD.
This study should be interpreted in the light of the following limitations: (1) sample size was relatively small and
consisted of individuals with mild-to-moderate PD, (2)
report of fall history relied on retrospective report, and
(3) testing only took place when participants oﬀ anti-PD
medication. Future studies should collect the occurrence of
falls on shorter time intervals such as one week or even
one day to improve fall report accuracy. Finally, clinicians
should consider testing people with PD both on and oﬀ
medication to gain a full understanding of functional status
and vulnerability to falls under both conditions due to
known fluctuations associated with anti-PD medications.

5. Conclusion
A single measurement of gait velocity, in any condition, was
less accurate than a more comprehensive balance measure.
Future studies could examine whether other aspects of gait
(e.g., stride length, symmetry, and interlimb coordination)
are more predictive of future falls in people with PD.
However, because of the multifactorial nature of falls, a single
item may not be as eﬀective as multi-item assessment tools
such as the Mini-BESTest.
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